skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:055994/0665   Pages: 8
Recorded: 04/21/2021
Attorney Dkt #:54LW-306090
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 6
1
Patent #:
Issue Dt:
05/12/2020
Application #:
15744734
Filing Dt:
01/12/2018
Publication #:
Pub Dt:
01/03/2019
Title:
ANTI-GM-CSF ANTIBODIES AND USES THEREOF
2
Patent #:
Issue Dt:
03/03/2020
Application #:
16069487
Filing Dt:
07/11/2018
Publication #:
Pub Dt:
07/25/2019
Title:
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
3
Patent #:
Issue Dt:
01/12/2021
Application #:
16100063
Filing Dt:
08/09/2018
Publication #:
Pub Dt:
12/20/2018
Title:
ANTI-GM-CSF ANTIBODIES AND USES THEREOF
4
Patent #:
Issue Dt:
04/13/2021
Application #:
16483870
Filing Dt:
08/06/2019
Publication #:
Pub Dt:
01/21/2021
Title:
ANTIBODIES TO T CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (TIGIT) AND USES THEREOF
5
Patent #:
Issue Dt:
08/16/2022
Application #:
16687387
Filing Dt:
11/18/2019
Publication #:
Pub Dt:
03/05/2020
Title:
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
6
Patent #:
Issue Dt:
03/12/2024
Application #:
17109924
Filing Dt:
12/02/2020
Publication #:
Pub Dt:
03/18/2021
Title:
ANTI-GM-CSF ANTIBODIES AND USES THEREOF
Assignor
1
Exec Dt:
03/23/2021
Assignee
1
6F, #3 BLD., HEXIANG TECHNOLOGY CENTER
QIANTANG NEW AREA
HANGZHOU, ZHEJIANG, CHINA
Correspondence name and address
SHEPPARD MULLIN RICHTER & HAMPTON LLP
379 LYTTON AVENUE
ALEX Y. NIE
PALO ALTO, CA 94301

Search Results as of: 06/19/2024 09:48 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT